Ruiyin Wang1,2, Jiangtao Lin2, Jingru Wang2, Chunxiao Li2. 1. Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China. 2. Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Abstract
OBJECTIVE: To observe the effects of artesunate on eosinophil (EOS) apoptosis and Fas and Bcl-2 protein expressions in asthmatic mice. METHODS: Thirty female BALB/c mice aged 6-8 weeks were randomly divided into control group, asthma group and artesunate group. Except for those in the control group, all the mice were sensitized with aerosolized ovalbumin to establish mouse models of asthma. In artesunate group, the rats were intraperitoneally injected with artesunate 1 h before ovalbumin inhalation from the 21st day of modeling. The lung tissues were harvested for staining 24 h after the last challenge. Flow cytometry was used to analyze the percentage and apoptosis rate of EOS in the alveolar lavage fluid (BALF). The apoptosis of EOS in the lung tissue was detected with TUNEL method, and Fas and Bcl-2 protein expressions were detected using immunohistochemistry. RESULTS: Compared with those in asthma group, the artesunate-treated mice had significantly decreased percentage of EOS in the BALF (P < 0.05) with increased apoptosis rate of EOS in the BALF and the lung tissue (P < 0.05). The Fas-positive area and IOD of Fas protein in the lung tissue increased (P < 0.05) while the Bcl-2-positive area and IOD of Bcl-2 protein decreased significantly in artesunate-treated mice as compared with the asthmatic mice (P < 0.05). CONCLUSIONS: Artesunate regulates the protein expressions of Fas and Bcl-2 to reduce EOS infiltration in the lung tissue and promote EOS apoptosis in asthmatic mice.
OBJECTIVE: To observe the effects of artesunate on eosinophil (EOS) apoptosis and Fas and Bcl-2 protein expressions in asthmatic mice. METHODS: Thirty female BALB/c mice aged 6-8 weeks were randomly divided into control group, asthma group and artesunate group. Except for those in the control group, all the mice were sensitized with aerosolized ovalbumin to establish mouse models of asthma. In artesunate group, the rats were intraperitoneally injected with artesunate 1 h before ovalbumin inhalation from the 21st day of modeling. The lung tissues were harvested for staining 24 h after the last challenge. Flow cytometry was used to analyze the percentage and apoptosis rate of EOS in the alveolar lavage fluid (BALF). The apoptosis of EOS in the lung tissue was detected with TUNEL method, and Fas and Bcl-2 protein expressions were detected using immunohistochemistry. RESULTS: Compared with those in asthma group, the artesunate-treated mice had significantly decreased percentage of EOS in the BALF (P < 0.05) with increased apoptosis rate of EOS in the BALF and the lung tissue (P < 0.05). The Fas-positive area and IOD of Fas protein in the lung tissue increased (P < 0.05) while the Bcl-2-positive area and IOD of Bcl-2 protein decreased significantly in artesunate-treated mice as compared with the asthmatic mice (P < 0.05). CONCLUSIONS:Artesunate regulates the protein expressions of Fas and Bcl-2 to reduce EOS infiltration in the lung tissue and promote EOS apoptosis in asthmatic mice.
Authors: Simon P Hogan; Helene F Rosenberg; Redwan Moqbel; Simon Phipps; Paul S Foster; Paige Lacy; A Barry Kay; Marc E Rothenberg Journal: Clin Exp Allergy Date: 2008-04-01 Impact factor: 5.018
Authors: Rahul Shrimanker; Oliver Keene; Gareth Hynes; Sally Wenzel; Steven Yancey; Ian D Pavord Journal: Am J Respir Crit Care Med Date: 2019-11-15 Impact factor: 21.405
Authors: Loren C Denlinger; Brenda R Phillips; Sima Ramratnam; Kristie Ross; Nirav R Bhakta; Juan Carlos Cardet; Mario Castro; Stephen P Peters; Wanda Phipatanakul; Shean Aujla; Leonard B Bacharier; Eugene R Bleecker; Suzy A A Comhair; Andrea Coverstone; Mark DeBoer; Serpil C Erzurum; Sean B Fain; Merritt Fajt; Anne M Fitzpatrick; Jonathan Gaffin; Benjamin Gaston; Annette T Hastie; Gregory A Hawkins; Fernando Holguin; Anne-Marie Irani; Elliot Israel; Bruce D Levy; Ngoc Ly; Deborah A Meyers; Wendy C Moore; Ross Myers; Maria Theresa D Opina; Michael C Peters; Mark L Schiebler; Ronald L Sorkness; W Gerald Teague; Sally E Wenzel; Prescott G Woodruff; David T Mauger; John V Fahy; Nizar N Jarjour Journal: Am J Respir Crit Care Med Date: 2017-02-01 Impact factor: 21.405
Authors: K L Woolley; P G Gibson; K Carty; A J Wilson; S H Twaddell; M J Woolley Journal: Am J Respir Crit Care Med Date: 1996-07 Impact factor: 21.405